MGIM
NEO icon

M&G Investment Management’s NeoGenomics NEO Stock Holding History

M&G Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29,928
Closed -$1.44M – 656
2021
Q3 		$1.44M Sell
29,928
-20,796
-41% -$963K ﹤0.01% 577
2021
Q2 		$2.28M Buy
+50,724
New +$2.25M 0.01% 500

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

M&G Investment Management's NEO Position: Q4 2021 in Review

M&G Investment Management sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 29,928 shares — an estimated $1.44M sold.

M&G Investment Management first reported a position in NEO in Q2 2021 and held it in 2 quarters. The position peaked at $2.28M in Q2 2021. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • M&G Investment Management reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 29,928 NeoGenomics shares in Q4 2021, an estimated $1.44M.
  • M&G Investment Management first reported a position in NeoGenomics in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's NeoGenomics position peaked at $2.28M in Q2 2021.
  • 307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.